JESSE GOODMAN

Insider Reports History

Location
Cambridge, MA
Signature
/s/ James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JESSE GOODMAN:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. Director Common Stock 24.4K $225K $9.23 01 Jul 2025 Direct
BiomX Inc. Director Common Stock Options - right to Buy 17.6K 14 Apr 2025 Direct
Intellia Therapeutics, Inc. Director Stock Option (right to buy) 11.5K 11 Jun 2025 Direct

Insider Reports Filed by JESSE GOODMAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NTLA Intellia Therapeutics, Inc. 30 Jun 2025 2 -$29.1K 4 Director 02 Jul 2025, 17:50
NTLA Intellia Therapeutics, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 16:33
PHGE BiomX Inc. 14 Apr 2025 1 $0 4/A Director 21 Apr 2025, 08:07
PHGE BiomX Inc. 11 Jul 2024 1 $0 4 Director 15 Jul 2024, 18:43
NTLA Intellia Therapeutics, Inc. 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 16:20
PHGE BiomX Inc. 15 Mar 2024 0 $0 3 Director 21 Mar 2024, 16:26
NTLA Intellia Therapeutics, Inc. 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 16:28
NTLA Intellia Therapeutics, Inc. 14 Jun 2022 2 $0 4 Director 16 Jun 2022, 18:36
NTLA Intellia Therapeutics, Inc. 23 Jun 2021 2 $0 4 Director 25 Jun 2021, 18:08